Prospective Multi Center Study of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS)
Status: Recruiting
Location: See all (3) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
This is a prospective international multi-center registry and biorepository trial of children and adolescents/young adults (AYA) undergoing hematopoietic cell transplantation (HCT) to assess the impact of endotheliopathies in the HCT setting as a contributor of significant morbidity and mortality.
Eligibility
Participation Requirements
Sex: All
Maximum Age: 26
Healthy Volunteers: f
View:
• Children, adolescents and young adults (AYA) 0-26 years of age undergoing HSCT.
• Recipients of autologous and allogeneic HSCT.
• Any preparative regimen.
Locations
United States
Minnesota
Mayo Clinic
RECRUITING
Rochester
North Carolina
Duke University
RECRUITING
Durham
Texas
MD Anderson Cancer Center
RECRUITING
Houston
Contact Information
Primary
LaTarsha Spencer
latarsha.spencer@duke.edu
(919) 613-1895
Time Frame
Start Date: 2019-11-19
Estimated Completion Date: 2026-02-05
Participants
Target number of participants: 500
Treatments
Biorepository trial of children and adolescents/young adults (AYA)
undergoing hematopoietic cell transplantation (HCT) to assess the impact of endotheliopathies in the HCT setting as a contributor of significant morbidity and mortality.
Related Therapeutic Areas
Sponsors
Leads: Duke University